Merrimack Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Merrimack Pharmaceuticals's estimated annual revenue is currently $7.5M per year.
- Merrimack Pharmaceuticals's estimated revenue per employee is $115,385
- Merrimack Pharmaceuticals's total funding is $288M.
Employee Data
- Merrimack Pharmaceuticals has 65 Employees.
- Merrimack Pharmaceuticals grew their employee count by 0% last year.
Merrimack Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Senior QA Compliance Specialist | Reveal Email/Phone |
2 | Associate process | Reveal Email/Phone |
3 | Chairman/President/Treasurer | Reveal Email/Phone |
Merrimack Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of novel treatments for diseases in the areas of immunology and oncology. Founded by leading scientists from MIT and Harvard, the company’s proprietary “Network Biology” discovery platform enables the high throughput profiling of protein networks as a basis for improved validation, lead identification and speed in the development of innovative, effective and safe therapeutics. Merrimack is a privately held company based in Cambridge, Massachusetts.
keywords:N/A
$288M
Total Funding
65
Number of Employees
$7.5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Merrimack Pharmaceuticals News
Merrimack Pharmaceuticals, Inc operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge,...
Merrimack Pharmaceuticals, Inc operates as a biopharmaceutical company. The company was founded in 1993 and is headquartered in Cambridge,...
DTT has received consulting fees from Tekla Capital Management, Ikena Oncology, NanoString Technologies, Pfizer, Merrimack Pharmaceuticals,...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 10, 2021-- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today announced its full year 2020 financial results for the period ended December 31, 2020. “We are pleased that both Ipsen Pharmaceuticals and Elevation Oncology co ...
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK), a clinical-stage oncology company focused on biomarker-defined cancers, today announced the closing of a $25 million term loan with Hercules Capital (NYSE: HTGC), $15 million of which was funded at closing today. Merrimack's current cash and cash e ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $12.3M | 65 | 48% | N/A |
#2 | $10.5M | 65 | 16% | N/A |
#3 | $7.5M | 65 | 8% | N/A |
#4 | $14.2M | 65 | -11% | N/A |
#5 | $8.8M | 65 | 2% | N/A |